Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Stuart Jay Schnitt, M.D.

TitleProfessor of Pathology
InstitutionBeth Israel Deaconess Medical Center
DepartmentPathology
AddressBeth Israel Deaconess Med Ctr
Pathology
330 Brookline Ave
Boston MA 02215
Phone617/667-4344
Fax617/975-5620

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Wong JS, Chen YH, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Smith BL, Troyan SL, Harris JR. Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). Breast Cancer Res Treat. 2014 Jan; 143(2):343-50.
    View in: PubMed
  2. Gilcrease MZ, Schnitt SJ, Morrow M. No benefit to intraoperative assessment of breast margins? Am J Clin Pathol. 2013 Oct; 140(4):597.
    View in: PubMed
  3. Schnitt SJ, Morrow M. The authors' reply. Am J Clin Pathol. 2013 Oct; 140(4):598.
    View in: PubMed
  4. Punglia RS, Schnitt SJ, Weeks JC. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? J Natl Cancer Inst. 2013 Oct 16; 105(20):1527-33.
    View in: PubMed
  5. Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, Connolly JL, Chen WY, Willett WC, Tamimi RM. Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst. 2013 Oct 16; 105(20):1571-8.
    View in: PubMed
  6. Dabbs DJ, Schnitt SJ, Geyer FC, Weigelt B, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Lakhani SR, Palacios J, Rakha E, Richardson AL, Schmitt FC, Tan PH, Tse GM, Vincent-Salomon A, Ellis IO, Badve S, Reis-Filho JS. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol. 2013 Jul; 37(7):e1-11.
    View in: PubMed
  7. Shin SJ, Lal A, De Vries S, Suzuki J, Roy R, Hwang ES, Schnitt SJ, Waldman FM, Chen YY. Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. Hum Pathol. 2013 Oct; 44(10):1998-2009.
    View in: PubMed
  8. Choudhury S, Almendro V, Merino VF, Wu Z, Maruyama R, Su Y, Martins FC, Fackler MJ, Bessarabova M, Kowalczyk A, Conway T, Beresford-Smith B, Macintyre G, Cheng YK, Lopez-Bujanda Z, Kaspi A, Hu R, Robens J, Nikolskaya T, Haakensen VD, Schnitt SJ, Argani P, Ethington G, Panos L, Grant M, Clark J, Herlihy W, Lin SJ, Chew G, Thompson EW, Greene-Colozzi A, Richardson AL, Rosson GD, Pike M, Garber JE, Nikolsky Y, Blum JL, Au A, Hwang ES, Tamimi RM, Michor F, Haviv I, Liu XS, Sukumar S, Polyak K. Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27(+) Cell Population with Progenitor Characteristics. Cell Stem Cell. 2013 Jul 3; 13(1):117-30.
    View in: PubMed
  9. Collins LC, Achacoso N, Haque R, Nekhlyudov L, Fletcher SW, Quesenberry CP, Schnitt SJ, Habel LA. Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat. 2013 Jun; 139(2):453-60.
    View in: PubMed
  10. Aroner SA, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Rosner BA, Hankinson SE, Tamimi RM. Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies. Breast Cancer Res Treat. 2013 May; 139(1):277-85.
    View in: PubMed
  11. Beck AH, Knoblauch NW, Hefti MM, Kaplan J, Schnitt SJ, Culhane AC, Schroeder MS, Risch T, Quackenbush J, Haibe-Kains B. Significance analysis of prognostic signatures. PLoS Comput Biol. 2013 Jan; 9(1):e1002875.
    View in: PubMed
  12. Schnitt SJ, Morrow M. Should intraoperative frozen section evaluation of breast lumpectomy margins become routine practice? Am J Clin Pathol. 2012 Nov; 138(5):635-8.
    View in: PubMed
  13. Kaplan JS, Schnitt SJ, Collins LC, Wang Y, Garber JE, Montgomery K, West RB, Krag K, Fetten K, Lincoln A, Tung NM. Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers. Am J Surg Pathol. 2012 Oct; 36(10):1483-8.
    View in: PubMed
  14. Morrow M, Harris JR, Schnitt SJ. Surgical margins in lumpectomy for breast cancer--bigger is not better. N Engl J Med. 2012 Jul 5; 367(1):79-82.
    View in: PubMed
  15. Su X, Colditz GA, Collins LC, Baer HJ, Sampson LA, Willett WC, Berkey CS, Schnitt SJ, Connolly JL, Rosner BA, Tamimi RM. Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease. Breast Cancer Res Treat. 2012 Jul; 134(2):783-91.
    View in: PubMed
  16. Martins FC, De S, Almendro V, Gönen M, Park SY, Blum JL, Herlihy W, Ethington G, Schnitt SJ, Tung N, Garber JE, Fetten K, Michor F, Polyak K. Evolutionary pathways in BRCA1-associated breast tumors. Cancer Discov. 2012 Jun; 2(6):503-11.
    View in: PubMed
  17. Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Colditz GA. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics. 2012 May; 129(5):e1192-8.
    View in: PubMed
  18. Nekhlyudov L, Habel LA, Achacoso N, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP, Fletcher SW. Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS. J Natl Cancer Inst. 2012 Apr 18; 104(8):614-21.
    View in: PubMed
  19. Partridge AH, Elmore JG, Saslow D, McCaskill-Stevens W, Schnitt SJ. Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop. CA Cancer J Clin. 2012 May-Jun; 62(3):203-10.
    View in: PubMed
  20. Santagata S, Hu R, Lin NU, Mendillo ML, Collins LC, Hankinson SE, Schnitt SJ, Whitesell L, Tamimi RM, Lindquist S, Ince TA. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A. 2011 Nov 8; 108(45):18378-83.
    View in: PubMed
  21. Keller PJ, Arendt LM, Skibinski A, Logvinenko T, Klebba I, Dong S, Smith AE, Prat A, Perou CM, Gilmore H, Schnitt S, Naber SP, Garlick JA, Kuperwasser C. Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci U S A. 2012 Feb 21; 109(8):2772-7.
    View in: PubMed
  22. Tamimi RM, Colditz GA, Hazra A, Baer HJ, Hankinson SE, Rosner B, Marotti J, Connolly JL, Schnitt SJ, Collins LC. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(1):159-67.
    View in: PubMed
  23. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011 Aug 3; 103(15):1179-89.
    View in: PubMed
  24. Jung MM, Colditz GA, Collins LC, Schnitt SJ, Connolly JL, Tamimi RM. Lifetime physical activity and the incidence of proliferative benign breast disease. Cancer Causes Control. 2011 Sep; 22(9):1297-305.
    View in: PubMed
  25. Holmes MD, Chen WY, Schnitt SJ, Collins L, Colditz GA, Hankinson SE, Tamimi RM. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat. 2011 Nov; 130(2):657-62.
    View in: PubMed
  26. Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study. Mod Pathol. 2011 Jul; 24(7):924-31.
    View in: PubMed
  27. Liu Y, Tamimi RM, Collins LC, Schnitt SJ, Gilmore HL, Connolly JL, Colditz GA. The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study. Breast Cancer Res Treat. 2011 Aug; 129(1):175-84.
    View in: PubMed
  28. Krajcovic M, Johnson NB, Sun Q, Normand G, Hoover N, Yao E, Richardson AL, King RW, Cibas ES, Schnitt SJ, Brugge JS, Overholtzer M. A non-genetic route to aneuploidy in human cancers. Nat Cell Biol. 2011 Mar; 13(3):324-30.
    View in: PubMed
  29. Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ, Cole K, Marotti JD, Hankinson SE, Colditz GA, Tamimi RM. Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res. 2011 Apr 1; 17(7):1867-74.
    View in: PubMed
  30. Proia TA, Keller PJ, Gupta PB, Klebba I, Jones AD, Sedic M, Gilmore H, Tung N, Naber SP, Schnitt S, Lander ES, Kuperwasser C. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell. 2011 Feb 4; 8(2):149-63.
    View in: PubMed
  31. Lee LJ, Alexander B, Schnitt SJ, Comander A, Gallagher B, Garber JE, Tung N. Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers. Cancer. 2011 Jul 15; 117(14):3093-100.
    View in: PubMed
  32. Tamimi RM, Colditz GA, Wang Y, Collins LC, Hu R, Rosner B, Irie HY, Connolly JL, Schnitt SJ. Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer. Breast Cancer Res Treat. 2011 Jul; 128(1):243-50.
    View in: PubMed
  33. Robens J, Goldstein L, Gown AM, Schnitt SJ. Thyroid transcription factor-1 expression in breast carcinomas. Am J Surg Pathol. 2010 Dec; 34(12):1881-5.
    View in: PubMed
  34. Alexander BM, Sprott K, Farrow DA, Wang X, D'Andrea AD, Schnitt SJ, Collins LC, Weaver DT, Garber JE. DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer. Clin Cancer Res. 2010 Dec 1; 16(23):5796-804.
    View in: PubMed
  35. Tung N, Miron A, Schnitt SJ, Gautam S, Fetten K, Kaplan J, Yassin Y, Buraimoh A, Kim JY, Szász AM, Tian R, Wang ZC, Collins LC, Brock J, Krag K, Legare RD, Sgroi D, Ryan PD, Silver DP, Garber JE, Richardson AL. Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers. Breast Cancer Res. 2010; 12(6):R95.
    View in: PubMed
  36. Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Rakha EA, Richardson AL, Schmitt FC, Tan PH, Tse GM, Weigelt B, Ellis IO, Reis-Filho JS. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2011 Feb; 24(2):157-67.
    View in: PubMed
  37. Keller PJ, Lin AF, Arendt LM, Klebba I, Jones AD, Rudnick JA, DiMeo TA, Gilmore H, Jefferson DM, Graham RA, Naber SP, Schnitt S, Kuperwasser C. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res. 2010; 12(5):R87.
    View in: PubMed
  38. Dawood S, Hu R, Homes MD, Collins LC, Schnitt SJ, Connolly J, Colditz GA, Tamimi RM. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res Treat. 2011 Feb; 126(1):185-92.
    View in: PubMed
  39. Aroner SA, Collins LC, Schnitt SJ, Connolly JL, Colditz GA, Tamimi RM. Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Res. 2010; 12(4):R61.
    View in: PubMed
  40. Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Richardson AL, Schnitt SJ, Schmitt FC, Tan PH, Tse GM, Badve S, Ellis IO. Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res. 2010; 12(4):207.
    View in: PubMed
  41. Schnitt SJ. Molecular biology of breast tumor progression: a view from the other side. Int J Surg Pathol. 2010 Jun; 18(3 Suppl):170S-173S.
    View in: PubMed
  42. Schnitt SJ. Will molecular classification replace traditional breast pathology? Int J Surg Pathol. 2010 Jun; 18(3 Suppl):162S-166S.
    View in: PubMed
  43. Hilson JB, Schnitt SJ, Collins LC. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast. Am J Surg Pathol. 2010 Jun; 34(6):896-900.
    View in: PubMed
  44. Schnitt SJ. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol. 2010 May; 23 Suppl 2:S60-4.
    View in: PubMed
  45. Haque R, Achacoso NS, Fletcher SW, Nekhlyudov L, Collins LC, Schnitt SJ, Quesenberry CP, Habel LA. Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. Am J Manag Care. 2010 May; 16(5):351-60.
    View in: PubMed
  46. Su X, Tamimi RM, Collins LC, Baer HJ, Cho E, Sampson L, Willett WC, Schnitt SJ, Connolly JL, Rosner BA, Colditz GA. Intake of fiber and nuts during adolescence and incidence of proliferative benign breast disease. Cancer Causes Control. 2010 Jul; 21(7):1033-46.
    View in: PubMed
  47. Tung N, Wang Y, Collins LC, Kaplan J, Li H, Gelman R, Comander AH, Gallagher B, Fetten K, Krag K, Stoeckert KA, Legare RD, Sgroi D, Ryan PD, Garber JE, Schnitt SJ. Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features. Breast Cancer Res. 2010; 12(1):R12.
    View in: PubMed
  48. Schnitt SJ. Clinging carcinoma: an American perspective. Semin Diagn Pathol. 2010 Feb; 27(1):31-6.
    View in: PubMed
  49. Su X, Colditz GA, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Pollak MN, Rosner B, Tamimi RM. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. Int J Cancer. 2010 Jan 1; 126(1):180-90.
    View in: PubMed
  50. Schnitt SJ. Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics. J Natl Cancer Inst Monogr. 2010; 2010(41):158-61.
    View in: PubMed
  51. Collins LC, Achacoso N, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Puligandla B, Alshak NS, Goldstein LC, Gown AM, Schnitt SJ, Habel LA. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol. 2009 Dec; 33(12):1802-8.
    View in: PubMed
  52. Habel LA, Achacoso NS, Haque R, Nekhlyudov L, Fletcher SW, Schnitt SJ, Collins LC, Geiger AM, Puligandla B, Acton L, Quesenberry CP. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res. 2009; 11(6):R85.
    View in: PubMed
  53. Chen YY, Hwang ES, Roy R, DeVries S, Anderson J, Wa C, Fitzgibbons PL, Jacobs TW, MacGrogan G, Peterse H, Vincent-Salomon A, Tokuyasu T, Schnitt SJ, Waldman FM. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol. 2009 Nov; 33(11):1683-94.
    View in: PubMed
  54. Collins LC, Wang Y, Connolly JL, Baer HJ, Hu R, Schnitt SJ, Colditz GA, Tamimi RM. Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue. Appl Immunohistochem Mol Morphol. 2009 Oct; 17(5):438-41.
    View in: PubMed
  55. Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, Gown A, Hammond ME, Iglehart JD, Moench S, Pierce LJ, Ravdin P, Schnitt SJ, Wolff AC. NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. J Natl Compr Canc Netw. 2009 Sep; 7 Suppl 6:S1-S21; quiz S22-3.
    View in: PubMed
  56. Collins LC, Martyniak A, Kandel MJ, Stadler ZK, Masciari S, Miron A, Richardson AL, Schnitt SJ, Garber JE. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers. Am J Surg Pathol. 2009 Jul; 33(7):1093-7.
    View in: PubMed
  57. Nekhlyudov L, Habel LA, Achacoso NS, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP, Fletcher SW. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009 Jul 1; 27(19):3211-6.
    View in: PubMed
  58. Baer HJ, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies. Cancer. 2009 Apr 1; 115(7):1404-11.
    View in: PubMed
  59. Schnitt SJ. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin. Breast Cancer Res. 2009; 11(1):101.
    View in: PubMed
  60. Hu M, Peluffo G, Chen H, Gelman R, Schnitt S, Polyak K. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci U S A. 2009 Mar 3; 106(9):3372-7.
    View in: PubMed
  61. Hilson JB, Schnitt SJ, Collins LC. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications. Am J Surg Pathol. 2009 Feb; 33(2):227-32.
    View in: PubMed
  62. Jensen KC, Schaeffer DF, Cheang M, Montgomery K, West RB, Gilks CB, Ross D, Turashvili G, Schnitt S, van de Rijn M. Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue. Mod Pathol. 2008 Dec; 21(12):1413-20.
    View in: PubMed
  63. Kleer CG, Bloushtain-Qimron N, Chen YH, Carrasco D, Hu M, Yao J, Kraeft SK, Collins LC, Sabel MS, Argani P, Gelman R, Schnitt SJ, Krop IE, Polyak K. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin Cancer Res. 2008 Sep 1; 14(17):5357-67.
    View in: PubMed
  64. Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, Deitz AC, Connolly JL, Schnitt SJ, Colditz GA, Collins LC. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008; 10(4):R67.
    View in: PubMed
  65. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, Gelman RS, Allred C, Bissell MJ, Schnitt S, Polyak K. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell. 2008 May; 13(5):394-406.
    View in: PubMed
  66. Schnitt SJ, Harris JR. Evolution of breast-conserving therapy for localized breast cancer. J Clin Oncol. 2008 Mar 20; 26(9):1395-6.
    View in: PubMed
  67. Turner RR, Weaver DL, Cserni G, Lester SC, Hirsch K, Elashoff DA, Fitzgibbons PL, Viale G, Mazzarol G, Ibarra JA, Schnitt SJ, Giuliano AE. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J Clin Oncol. 2008 Jan 10; 26(2):258-63.
    View in: PubMed
  68. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008 Jan; 52(1):20-9.
    View in: PubMed
  69. Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW, Cibas ES, Brugge JS. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell. 2007 Nov 30; 131(5):966-79.
    View in: PubMed
  70. Collins LC, Achacoso NA, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Alshak NS, Puligandla B, Brodsky GL, Schnitt SJ, Habel LA. Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol. 2007 Nov; 20(11):1149-55.
    View in: PubMed
  71. Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE, Huntsman D. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet. 2007 Nov; 44(11):726-31.
    View in: PubMed
  72. Harton AM, Wang HH, Schnitt SJ, Jacobs TW. p63 Immunocytochemistry improves accuracy of diagnosis with fine-needle aspiration of the breast. Am J Clin Pathol. 2007 Jul; 128(1):80-5.
    View in: PubMed
  73. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007 Mar; 11(3):259-73.
    View in: PubMed
  74. Harris LN, You F, Schnitt SJ, Witkiewicz A, Lu X, Sgroi D, Ryan PD, Come SE, Burstein HJ, Lesnikoski BA, Kamma M, Friedman PN, Gelman R, Iglehart JD, Winer EP. Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Clin Cancer Res. 2007 Feb 15; 13(4):1198-207.
    View in: PubMed
  75. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer. 2007 Jan 15; 109(2):180-7.
    View in: PubMed
  76. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Cancer. 2006 Sep 15; 107(6):1240-7.
    View in: PubMed
  77. Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol. 2006 Aug; 30(8):1002-7.
    View in: PubMed
  78. Lim M, Bellon JR, Gelman R, Silver B, Recht A, Schnitt SJ, Harris JR. A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1149-54.
    View in: PubMed
  79. Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol. 2006 May; 19(5):617-21.
    View in: PubMed
  80. Schnitt SJ. Estrogen receptor testing of breast cancer in current clinical practice: what's the question? J Clin Oncol. 2006 Apr 20; 24(12):1797-9.
    View in: PubMed
  81. Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006 Mar 1; 24(7):1031-6.
    View in: PubMed
  82. O'Malley FP, Mohsin SK, Badve S, Bose S, Collins LC, Ennis M, Kleer CG, Pinder SE, Schnitt SJ. Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol. 2006 Feb; 19(2):172-9.
    View in: PubMed
  83. Harris LN, Broadwater G, Lin NU, Miron A, Schnitt SJ, Cowan D, Lara J, Bleiweiss I, Berry D, Ellis M, Hayes DF, Winer EP, Dressler L. Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342. Breast Cancer Res. 2006; 8(6):R66.
    View in: PubMed
  84. Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, Heywang-Köbrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Thickman D, Stelling CB, Weatherall PT, Lehman C, Gatsonis CA. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology. 2006 Jan; 238(1):42-53.
    View in: PubMed
  85. Krop I, März A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerbäck C, Polyak K. A putative role for psoriasin in breast tumor progression. Cancer Res. 2005 Dec 15; 65(24):11326-34.
    View in: PubMed
  86. Baer HJ, Schnitt SJ, Connolly JL, Byrne C, Willett WC, Rosner B, Colditz GA. Early life factors and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2889-97.
    View in: PubMed
  87. Schnall MD, Blume J, Bluemke DA, Deangelis GA, Debruhl N, Harms S, Heywang-Köbrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Smazal SF, Stelling CB, Lehman C, Weatherall PT, Gatsonis CA. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005 Oct 1; 92(1):32-8.
    View in: PubMed
  88. Hsiung PL, Pantanowitz L, Aguirre AD, Chen Y, Phatak D, Ko TH, Bourquin S, Schnitt SJ, Raza S, Connolly JL, Mashimo H, Fujimoto JG. Ultrahigh-resolution and 3-dimensional optical coherence tomography ex vivo imaging of the large and small intestines. Gastrointest Endosc. 2005 Oct; 62(4):561-74.
    View in: PubMed
  89. Lehman CD, Blume JD, Thickman D, Bluemke DA, Pisano E, Kuhl C, Julian TB, Hylton N, Weatherall P, O'loughlin M, Schnitt SJ, Gatsonis C, Schnall MD. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005 Oct 1; 92(1):9-15; discussion 15-6.
    View in: PubMed
  90. Tamimi RM, Byrne C, Baer HJ, Rosner B, Schnitt SJ, Connolly JL, Colditz GA. Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control study. Breast Cancer Res. 2005; 7(4):R555-62.
    View in: PubMed
  91. Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study. Cancer. 2005 May 1; 103(9):1778-84.
    View in: PubMed
  92. Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, Pisano E, Schnitt SJ, Gatsonis C, Schnall M, DeAngelis GA, Stomper P, Rosen EL, O'Loughlin M, Harms S, Bluemke DA. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005 May 1; 103(9):1898-905.
    View in: PubMed
  93. Collins LC, Schnitt SJ. HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy. Mod Pathol. 2005 May; 18(5):615-20.
    View in: PubMed
  94. Galper S, Blood E, Gelman R, Abner A, Recht A, Kohli A, Wong JS, Smith D, Bellon J, Connolly J, Schnitt S, Winer E, Silver B, Harris JR. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2005 Feb 1; 61(2):348-57.
    View in: PubMed
  95. Collins LC, Botero ML, Schnitt SJ. Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. Am J Clin Pathol. 2005 Jan; 123(1):16-20.
    View in: PubMed
  96. Bluemke DA, Gatsonis CA, Chen MH, DeAngelis GA, DeBruhl N, Harms S, Heywang-Köbrunner SH, Hylton N, Kuhl CK, Lehman C, Pisano ED, Causer P, Schnitt SJ, Smazal SF, Stelling CB, Weatherall PT, Schnall MD. Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004 Dec 8; 292(22):2735-42.
    View in: PubMed
  97. Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer. 2004 Oct 1; 101(7):1490-500.
    View in: PubMed
  98. Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs TW, Baer HJ, Willett WC, Colditz GA. A prospective study of diet and benign breast disease. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1106-13.
    View in: PubMed
  99. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004 Jul; 6(1):17-32.
    View in: PubMed
  100. Thurman SA, Schnitt SJ, Connolly JL, Gelman R, Silver B, Harris JR, Recht A. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys. 2004 May 1; 59(1):152-9.
    View in: PubMed
  101. Fajardo LL, Pisano ED, Caudry DJ, Gatsonis CA, Berg WA, Connolly J, Schnitt S, Page DL, McNeil BJ. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study. Acad Radiol. 2004 Mar; 11(3):293-308.
    View in: PubMed
  102. Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC. HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol. 2004 Mar 1; 22(5):854-63.
    View in: PubMed
  103. Collins LC, Connolly JL, Page DL, Goulart RA, Pisano ED, Fajardo LL, Berg WA, Caudry DJ, McNeil BJ, Schnitt SJ. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol. 2004 Jan; 28(1):126-31.
    View in: PubMed
  104. Baer HJ, Schnitt SJ, Connolly JL, Byrne C, Cho E, Willett WC, Colditz GA. Adolescent diet and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev. 2003 Nov; 12(11 Pt 1):1159-67.
    View in: PubMed
  105. Schnitt SJ. Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going? Am J Clin Pathol. 2003 Oct; 120(4):485-8.
    View in: PubMed
  106. Schnitt SJ. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia--classification, pathologic features and clinical significance. Breast Cancer Res. 2003; 5(5):263-8.
    View in: PubMed
  107. Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol. 2003 Jun; 27(6):836-41.
    View in: PubMed
  108. Schnitt SJ, Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol. 2003 May; 10(3):113-24.
    View in: PubMed
  109. Schnitt SJ. Images in pathology. Conversation between needle biopsies. Int J Surg Pathol. 2003 Apr; 11(2):117.
    View in: PubMed
  110. Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richardson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K. Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res. 2003 Mar; 1(5):362-75.
    View in: PubMed
  111. Schnitt SJ. Pharmacopathology: a new spin on an old idea. Am J Surg Pathol. 2003 Jan; 27(1):121-3.
    View in: PubMed
  112. Byrne C, Webb PM, Jacobs TW, Peiro G, Schnitt SJ, Connolly JL, Willett WC, Colditz GA. Alcohol consumption and incidence of benign breast disease. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1369-74.
    View in: PubMed
  113. Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Harris Ja, O'Malley F, Schnitt SJ, Singletary SE, Winchester DP. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002 Sep-Oct; 52(5):256-76.
    View in: PubMed
  114. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol. 2002 Sep; 26(9):1095-110.
    View in: PubMed
  115. Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Giuliano A, Harris JR, O'Malley F, Schnitt SJ, Singletary SE, Winchester DP. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002 Sep-Oct; 52(5):277-300.
    View in: PubMed
  116. Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs T, Peiro G, Willett W, Colditz GA. Family history of breast cancer, age and benign breast disease. Int J Cancer. 2002 Jul 20; 100(3):375-8.
    View in: PubMed
  117. Enerbäck C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S, Morton CC, Schnitt S, Pitts RL, Stampl J, Barnhart K, Polyak K. Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res. 2002 Jan 1; 62(1):43-7.
    View in: PubMed
  118. Jacobs TW, Schnitt SJ, Tan X, Brown LF. Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation. Hum Pathol. 2002 Jan; 33(1):29-38.
    View in: PubMed
  119. Khalkhali I, Baum JK, Villanueva-Meyer J, Edell SL, Hanelin LG, Lugo CE, Taillefer R, Freeman LM, Neal CE, Scheff AM, Connolly JL, Schnitt SJ, Houlihan MJ, Sampalis JS, Haber SB. (99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. Radiology. 2002 Jan; 222(1):149-55.
    View in: PubMed
  120. Schnitt SJ, Jacobs TW. Current status of HER2 testing: caught between a rock and a hard place. Am J Clin Pathol. 2001 Dec; 116(6):806-10.
    View in: PubMed
  121. Schnitt SJ. Benign breast disease and breast cancer risk: potential role for antiestrogens. Clin Cancer Res. 2001 Dec; 7(12 Suppl):4419s-4422s; discussion 4411s-4412s.
    View in: PubMed
  122. Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9796-801.
    View in: PubMed
  123. Pisano ED, Fajardo LL, Caudry DJ, Sneige N, Frable WJ, Berg WA, Tocino I, Schnitt SJ, Connolly JL, Gatsonis CA, McNeil BJ. Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V. Radiology. 2001 Jun; 219(3):785-92.
    View in: PubMed
  124. Lehr HA, Jacobs TW, Yaziji H, Schnitt SJ, Gown AM. Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol. 2001 Jun; 115(6):814-22.
    View in: PubMed
  125. Schnitt SJ. Breast cancer in the 21st century: neu opportunities and neu challenges. Mod Pathol. 2001 Mar; 14(3):213-8.
    View in: PubMed
  126. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Pathologic features of breast cancers in women with previous benign breast disease. Am J Clin Pathol. 2001 Mar; 115(3):362-9.
    View in: PubMed
  127. Jacobs TW, Pliss N, Kouria G, Schnitt SJ. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol. 2001 Feb; 25(2):229-36.
    View in: PubMed
  128. Schnitt SJ. Traditional and newer pathologic factors. J Natl Cancer Inst Monogr. 2001; (30):22-6.
    View in: PubMed
  129. Janov AJ, Tulecke M, O'Neill A, Lester S, Mauch PM, Harris J, Schnitt SJ, Shapiro CL. Clinical and pathologic features of breast cancers in women treated for Hodgkin's disease: a case-control study. Breast J. 2001 Jan-Feb; 7(1):46-52.
    View in: PubMed
  130. Khalkhali I, Villanueva-Meyer J, Edell SL, Connolly JL, Schnitt SJ, Baum JK, Houlihan MJ, Jenkins RM, Haber SB. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med. 2000 Dec; 41(12):1973-9.
    View in: PubMed
  131. Byrne C, Connolly JL, Colditz GA, Schnitt SJ. Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk. Cancer. 2000 Nov 15; 89(10):2046-52.
    View in: PubMed
  132. Siziopikou KP, Schnitt SJ. MIB-1 Proliferation Index in Ductal Carcinoma In Situ of the Breast: Relationship to the Expression of the Apoptosis-Regulating Proteins bcl-2 and p53. Breast J. 2000 Nov; 6(6):400-406.
    View in: PubMed
  133. Galper S, Recht A, Silver B, Bernardo MV, Gelman R, Wong J, Schnitt SJ, Connolly JL, Harris JR. Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy. Int J Radiat Oncol Biol Phys. 2000 Aug 1; 48(1):125-32.
    View in: PubMed
  134. Wong JS, O'Neill A, Recht A, Schnitt SJ, Connolly JL, Silver B, Harris JR. The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection? Int J Radiat Oncol Biol Phys. 2000 Aug 1; 48(1):133-7.
    View in: PubMed
  135. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000 Jul; 124(7):966-78.
    View in: PubMed
  136. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000 Apr; 18(8):1668-75.
    View in: PubMed
  137. Abner AL, Connolly JL, Recht A, Bornstein B, Nixon A, Hetelekidis S, Silver B, Harris JR, Schnitt SJ. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer. 2000 Mar 1; 88(5):1072-7.
    View in: PubMed
  138. Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ. HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. Am J Clin Pathol. 2000 Feb; 113(2):251-8.
    View in: PubMed
  139. Morrow M, Schnitt SJ. Treatment selection in ductal carcinoma in situ. JAMA. 2000 Jan 26; 283(4):453-5.
    View in: PubMed
  140. Peiro G, Bornstein BA, Connolly JL, Gelman R, Hetelekidis S, Nixon AJ, Recht A, Silver B, Harris JR, Schnitt SJ. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat. 2000 Jan; 59(1):49-54.
    View in: PubMed
  141. Hetelekidis S, Schnitt SJ, Silver B, Manola J, Bornstein BA, Nixon AJ, Recht A, Gelman R, Harris JR, Connolly JL. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2000 Jan 1; 46(1):31-4.
    View in: PubMed
  142. Galper S, Recht A, Silver B, Manola J, Gelman R, Schnitt SJ, Connolly JL, Harris JR. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys. 1999 Dec 1; 45(5):1157-66.
    View in: PubMed
  143. Gertig DM, Stillman IE, Byrne C, Spiegelman D, Schnitt SJ, Connolly JL, Colditz GA, Hunter DJ. Association of age and reproductive factors with benign breast tissue composition. Cancer Epidemiol Biomarkers Prev. 1999 Oct; 8(10):873-9.
    View in: PubMed
  144. Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol. 1999 Oct; 12(10):941-5.
    View in: PubMed
  145. Schnitt SJ, Morrow M. Lobular carcinoma in situ: current concepts and controversies. Semin Diagn Pathol. 1999 Aug; 16(3):209-23.
    View in: PubMed
  146. Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ. Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. J Clin Oncol. 1999 Jul; 17(7):1974-82.
    View in: PubMed
  147. Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ. Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol. 1999 Jul; 17(7):1983-7.
    View in: PubMed
  148. Siziopikou KP, Schnitt SJ, Connolly JL, Hayes DF. Detection and Significance of Occult Axillary Metastatic Disease in Breast Cancer Patients. Breast J. 1999 Jul; 5(4):221-229.
    View in: PubMed
  149. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res. 1999 May; 5(5):1041-56.
    View in: PubMed
  150. Jacobs TW, Silverman JF, Schroeder B, Raza S, Baum JK, Schnitt SJ. Accuracy of touch imprint cytology of image-directed breast core needle biopsies. Acta Cytol. 1999 Mar-Apr; 43(2):169-74.
    View in: PubMed
  151. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med. 1999 Feb 11; 340(6):430-6.
    View in: PubMed
  152. Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, Lester S, Lyons JA, Harris JR, Schnitt SJ. Predictors of local recurrence following excision alone for ductal carcinoma in situ. Cancer. 1999 Jan 15; 85(2):427-31.
    View in: PubMed
  153. Abner AL, Collins L, Peiro G, Recht A, Come S, Shulman LN, Silver B, Nixon A, Harris JR, Schnitt SJ, Connolly JL. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Cancer. 1998 Dec 15; 83(12):2502-8.
    View in: PubMed
  154. Fraser JL, Raza S, Chorny K, Connolly JL, Schnitt SJ. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol. 1998 Dec; 22(12):1521-7.
    View in: PubMed
  155. Schnitt SJ. Microinvasive carcinoma of the breast: a diagnosis in search of a definition. Adv Anat Pathol. 1998 Nov; 5(6):367-72.
    View in: PubMed
  156. Slavin SA, Schnitt SJ, Duda RB, Houlihan MJ, Koufman CN, Morris DJ, Troyan SL, Goldwyn RM. Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer. Plast Reconstr Surg. 1998 Jul; 102(1):49-62.
    View in: PubMed
  157. Chabner E, Nixon A, Gelman R, Hetelekidis S, Recht A, Bornstein B, Connolly J, Schnitt S, Silver B, Manola J, Harris J, Garber J. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1998 Jun; 16(6):2045-51.
    View in: PubMed
  158. Jacobs TW, Siziopikou KP, Prioleau JE, Raza S, Baum JK, Hayes DF, Schnitt SJ. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor? Mod Pathol. 1998 Mar; 11(3):259-64.
    View in: PubMed
  159. Schnitt SJ. Can we identify patients with invasive breast cancer adequately treated with breast-conserving surgery alone? Mod Pathol. 1998 Feb; 11(2):129-33.
    View in: PubMed
  160. Connolly JL, Boyages J, Nixon AJ, Peiró G, Gage I, Silver B, Recht A, Harris JR, Schnitt SJ. Predictors of breast recurrence after conservative surgery and radiation therapy for invasive breast cancer. Mod Pathol. 1998 Feb; 11(2):134-9.
    View in: PubMed
  161. Gage I, Schnitt SJ, Recht A, Abner A, Come S, Shulman LN, Monson JM, Silver B, Harris JR, Connolly JL. Skin recurrences after breast-conserving therapy for early-stage breast cancer. J Clin Oncol. 1998 Feb; 16(2):480-6.
    View in: PubMed
  162. Chen YY, Schnitt SJ. Prognostic factors for patients with breast cancers 1cm and smaller. Breast Cancer Res Treat. 1998; 51(3):209-25.
    View in: PubMed
  163. Guidi AJ, Schnitt SJ, Fischer L, Tognazzi K, Harris JR, Dvorak HF, Brown LF. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer. 1997 Nov 15; 80(10):1945-53.
    View in: PubMed
  164. Jin L, Yuan RQ, Fuchs A, Yao Y, Joseph A, Schwall R, Schnitt SJ, Guida A, Hastings HM, Andres J, Turkel G, Polverini PJ, Goldberg ID, Rosen EM. Expression of interleukin-1beta in human breast carcinoma. Cancer. 1997 Aug 1; 80(3):421-34.
    View in: PubMed
  165. Schnitt SJ, Connolly JL. Classification of ductal carcinoma in situ: striving for clinical relevance in the era of breast conserving therapy. Hum Pathol. 1997 Aug; 28(8):877-80.
    View in: PubMed
  166. Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997 May; 6(5):297-301.
    View in: PubMed
  167. Guidi AJ, Connolly JL, Harris JR, Schnitt SJ. The relationship between shaved margin and inked margin status in breast excision specimens. Cancer. 1997 Apr 15; 79(8):1568-73.
    View in: PubMed
  168. Gollamudi SV, Gelman RS, Peiro G, Schneider LJ, Schnitt SJ, Recht A, Silver BJ, Harris JR, Connolly JL. Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma. Cancer. 1997 Apr 1; 79(7):1362-9.
    View in: PubMed
  169. Jin L, Fuchs A, Schnitt SJ, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID, Rosen EM. Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer. 1997 Feb 15; 79(4):749-60.
    View in: PubMed
  170. Chabner E, Schnitt S, Harris J. Current Management of Patients with Ductal Carcinoma-in-Situ. Oncologist. 1997; 2(2):76-82.
    View in: PubMed
  171. Gage I, Schnitt SJ, Nixon AJ, Silver B, Recht A, Troyan SL, Eberlein T, Love SM, Gelman R, Harris JR, Connolly JL. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer. 1996 Nov 1; 78(9):1921-8.
    View in: PubMed
  172. Nixon AJ, Schnitt SJ, Gelman R, Gage I, Bornstein B, Hetelekidis S, Recht A, Silver B, Harris JR, Connolly JL. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer. 1996 Oct 1; 78(7):1426-31.
    View in: PubMed
  173. Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst. 1996 Aug 7; 88(15):1054-9.
    View in: PubMed
  174. Schnitt SJ, Harris JR, Smith BL. Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet? Cancer. 1996 Jun 1; 77(11):2189-92.
    View in: PubMed
  175. Bodis S, Siziopikou KP, Schnitt SJ, Harris JR, Fisher DE. Extensive apoptosis in ductal carcinoma in situ of the breast. Cancer. 1996 May 1; 77(9):1831-5.
    View in: PubMed
  176. Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J, Schnitt S, Livingston DM. Location of BRCA1 in human breast and ovarian cancer cells. Science. 1996 Apr 5; 272(5258):123-6.
    View in: PubMed
  177. Schnitt SJ, Hayman J, Gelman R, Eberlein TJ, Love SM, Mayzel K, Osteen RT, Nixon AJ, Pierce S, Connolly JL, Cohen P, Schneider L, Silver B, Recht A, Harris JR. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer. 1996 Mar 15; 77(6):1094-100.
    View in: PubMed
  178. Siziopikou KP, Prioleau JE, Harris JR, Schnitt SJ. bcl-2 expression in the spectrum of preinvasive breast lesions. Cancer. 1996 Feb 1; 77(3):499-506.
    View in: PubMed
  179. Panico L, D'Antonio A, Salvatore G, Mezza E, Tortora G, De Laurentiis M, De Placido S, Giordano T, Merino M, Salomon DS, Mullick WJ, Pettinato G, Schnitt SJ, Bianco AR, Ciardiello F. Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int J Cancer. 1996 Jan 3; 65(1):51-6.
    View in: PubMed
  180. Joshi MG, Lee AK, Pedersen CA, Schnitt S, Camus MG, Hughes KS. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast. Mod Pathol. 1996 Jan; 9(1):57-62.
    View in: PubMed
  181. Morrow M, Harris JR, Schnitt SJ. Local control following breast-conserving surgery for invasive cancer: results of clinical trials. J Natl Cancer Inst. 1995 Nov 15; 87(22):1669-73.
    View in: PubMed
  182. Connolly JL, Harris JR, Schnitt SJ. Understanding the distribution of cancer within the breast is important for optimizing breast-conserving treatment. Cancer. 1995 Jul 1; 76(1):1-3.
    View in: PubMed
  183. Hetelekidis S, Schnitt SJ, Morrow M, Harris JR. Management of ductal carcinoma in situ. CA Cancer J Clin. 1995 Jul-Aug; 45(4):244-53.
    View in: PubMed
  184. Prioleau J, Schnitt SJ. p53 antigen loss in stored paraffin slides. N Engl J Med. 1995 Jun 1; 332(22):1521-2.
    View in: PubMed
  185. Hiramatsu H, Bornstein BA, Recht A, Schnitt SJ, Baum JK, Connolly JL, Duda RB, Guidi AJ, Kaelin CM, Silver EB, Harris JR. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history. Cancer J Sci Am. 1995 May-Jun; 1(1):55-61.
    View in: PubMed
  186. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol. 1995 Jan; 26(1):86-91.
    View in: PubMed
  187. Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, Eberlein TJ, Mayzel K, Silver B, Harris JR. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 1994 Sep 15; 74(6):1746-51.
    View in: PubMed
  188. Nixon AJ, Recht A, Neuberg D, Connolly JL, Schnitt S, Abner A, Harris JR. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys. 1994 Aug 30; 30(1):17-21.
    View in: PubMed
  189. Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, Abner A, Recht A, Vicini F, Harris JR. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol. 1994 May; 12(5):888-94.
    View in: PubMed
  190. Guidi AJ, Fischer L, Harris JR, Schnitt SJ. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst. 1994 Apr 20; 86(8):614-9.
    View in: PubMed
  191. Schnitt SJ, Goldwyn RM, Slavin SA. Mammary ducts in the areola: implications for patients undergoing reconstructive surgery of the breast. Plast Reconstr Surg. 1993 Dec; 92(7):1290-3.
    View in: PubMed
  192. Waller BF, Johnson DE, Schnitt SJ, Pinkerton CA, Simpson JB, Baim DS. Histologic analysis of directional coronary atherectomy samples. A review of findings and their clinical relevance. Am J Cardiol. 1993 Oct 18; 72(13):80E-87E.
    View in: PubMed
  193. Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993 Aug; 11(8):1545-52.
    View in: PubMed
  194. Fisher DE, Schnitt SJ, Christian R, Harris JR, Henderson IC. Chest wall recurrence of ductal carcinoma in situ of the breast after mastectomy. Cancer. 1993 May 15; 71(10):3025-8.
    View in: PubMed
  195. Schnitt SJ, Jimi A, Kojiro M. The increasing prevalence of benign proliferative breast lesions in Japanese women. Cancer. 1993 Apr 15; 71(8):2528-31.
    View in: PubMed
  196. Schnitt SJ, Stillman IE, Owings DV, Kishimoto C, Dvorak HF, Abelmann WH. Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy. Circ Res. 1993 Apr; 72(4):914-20.
    View in: PubMed
  197. Miller MJ, Kuntz RE, Friedrich SP, Leidig GA, Fishman RF, Schnitt SJ, Baim DS, Safian RD. Frequency and consequences of intimal hyperplasia in specimens retrieved by directional atherectomy of native primary coronary artery stenoses and subsequent restenoses. Am J Cardiol. 1993 Mar 15; 71(8):652-8.
    View in: PubMed
  198. Connolly JL, Schnitt SJ. Benign breast disease. Resolved and unresolved issues. Cancer. 1993 Feb 15; 71(4):1187-9.
    View in: PubMed
  199. Abner AL, Recht A, Eberlein T, Come S, Shulman L, Hayes D, Connolly JL, Schnitt SJ, Silver B, Harris JR. Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1993 Jan; 11(1):44-8.
    View in: PubMed
  200. Connolly JL, Schnitt SJ. Clinical and histologic aspects of proliferative and non-proliferative benign breast disease. J Cell Biochem Suppl. 1993; 17G:45-8.
    View in: PubMed
  201. Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, Page DL. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol. 1992 Dec; 16(12):1133-43.
    View in: PubMed
  202. Pierce SM, Schnitt SJ, Harris JR. What to do about mammographically detected ductal carcinoma in situ? Cancer. 1992 Nov 15; 70(10):2576-8.
    View in: PubMed
  203. Fishman RF, Kuntz RE, Carrozza JP, Miller MJ, Senerchia CC, Schnitt SJ, Diver DJ, Safian RD, Baim DS. Long-term results of directional coronary atherectomy: predictors of restenosis. J Am Coll Cardiol. 1992 Nov 1; 20(5):1101-10.
    View in: PubMed
  204. Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol. 1992 Sep; 23(9):974-9.
    View in: PubMed
  205. Pomerantz RM, Kuntz RE, Carrozza JP, Fishman RF, Mansour M, Schnitt SJ, Safian RD, Baim DS. Acute and long-term outcome of narrowed saphenous venous grafts treated by endoluminal stenting and directional atherectomy. Am J Cardiol. 1992 Jul 15; 70(2):161-7.
    View in: PubMed
  206. Schnitt SJ, Connolly JL. Processing and evaluation of breast excision specimens. A clinically oriented approach. Am J Clin Pathol. 1992 Jul; 98(1):125-37.
    View in: PubMed
  207. Schnitt SJ, Safian RD, Kuntz RE, Schmidt DA, Baim DS. Histologic findings in specimens obtained by percutaneous directional coronary atherectomy. Hum Pathol. 1992 Apr; 23(4):415-20.
    View in: PubMed
  208. Mangano MM, Antonioli DA, Schnitt SJ, Wang HH. Nature and significance of cells with irregular nuclear contours in esophageal mucosal biopsies. Mod Pathol. 1992 Mar; 5(2):191-6.
    View in: PubMed
  209. Bur ME, Zimarowski MJ, Schnitt SJ, Baker S, Lew R. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer. 1992 Mar 1; 69(5):1174-81.
    View in: PubMed
  210. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992 Feb 19; 267(7):941-4.
    View in: PubMed
  211. Ducatman BS, Wang HH, Connolly JL, Schnitt SJ. FNA identification of familial breast disease. Am J Clin Pathol. 1992 Feb; 97(2):291; author reply 292-3.
    View in: PubMed
  212. Vicini FA, Recht A, Abner A, Boyages J, Cady B, Connolly JL, Gelman R, Osteen RT, Schnitt SJ, Silen W, et al. Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. J Natl Cancer Inst Monogr. 1992; (11):33-9.
    View in: PubMed
  213. Abelmann WH, Baim DS, Schnitt SJ. Endomyocardial biopsy: is it of clinical value? Postgrad Med J. 1992; 68 Suppl 1:S44-6.
    View in: PubMed
  214. Kuntz RE, Piana R, Schnitt SJ, Johnson RG, Safian RD, Baim DS. Early ostial vein graft stenosis: management by atherectomy. Cathet Cardiovasc Diagn. 1991 Sep; 24(1):41-4.
    View in: PubMed
  215. Vicini FA, Eberlein TJ, Connolly JL, Recht A, Abner A, Schnitt SJ, Silen W, Harris JR. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg. 1991 Sep; 214(3):200-4; discussion 204-5.
    View in: PubMed
  216. Reis GJ, Pomerantz RM, Jenkins RD, Kuntz RE, Baim DS, Diver DJ, Schnitt SJ, Safian RD. Laser balloon angioplasty: clinical, angiographic and histologic results. J Am Coll Cardiol. 1991 Jul; 18(1):193-202.
    View in: PubMed
  217. Login GR, Schnitt SJ, Dvorak AM. Correspondence re: N. Azumi, J. Joyce, and H. Battifora. Does rapid microwave fixation improve immunohistochemistry? Mod Pathol 3:368, 1990. Mod Pathol. 1991 Jan; 4(1):126-8.
    View in: PubMed
  218. Login GR, Schnitt SJ, Dvorak AM. Microwave fixation provides rapid, primary fixation for light and electron microscopy and for immunohistochemistry and immunocytochemistry. Eur J Morphol. 1991; 29(3):206-10.
    View in: PubMed
  219. Bornstein BA, Recht A, Connolly JL, Schnitt SJ, Cady B, Koufman C, Love S, Osteen RT, Harris JR. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer. 1991 Jan 1; 67(1):7-13.
    View in: PubMed
  220. Harris JR, Schnitt SJ. Is radiotherapy as curative as mastectomy for patients with ductal carcinoma in situ? Int J Radiat Oncol Biol Phys. 1990 Oct; 19(4):1091-2; discussion 1103.
    View in: PubMed
  221. Harris JR, Recht A, Connolly J, Cady B, Come S, Henderson IC, Koufman C, Love S, Schnitt S, Osteen R. Conservative surgery and radiotherapy for early breast cancer. Cancer. 1990 Sep 15; 66(6 Suppl):1427-38.
    View in: PubMed
  222. Boyages J, Recht A, Connolly JL, Schnitt SJ, Gelman R, Kooy H, Love S, Osteen RT, Cady B, Silver B, et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol. 1990 Sep; 19(1):29-41.
    View in: PubMed
  223. Safian RD, Gelbfish JS, Erny RE, Schnitt SJ, Schmidt DA, Baim DS. Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation. 1990 Jul; 82(1):69-79.
    View in: PubMed
  224. Eberlein TJ, Connolly JL, Schnitt SJ, Recht A, Osteen RT, Harris JR. Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. Arch Surg. 1990 Jun; 125(6):771-5; discussion 775-7.
    View in: PubMed
  225. Owings DV, Hann L, Schnitt SJ. How thoroughly should needle localization breast biopsies be sampled for microscopic examination? A prospective mammographic/pathologic correlative study. Am J Surg Pathol. 1990 Jun; 14(6):578-83.
    View in: PubMed
  226. Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JH, Verbeek AL, Schnitt SJ, Silver B, Boyages J, Harris JR. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 1990 Jan; 8(1):113-8.
    View in: PubMed
  227. Healey EA, Osteen RT, Schnitt SJ, Gelman R, Stomper PC, Connolly JL, Harris JR. Can the clinical and mammographic findings at presentation predict the presence of an extensive intraductal component in early stage breast cancer? Int J Radiat Oncol Biol Phys. 1989 Dec; 17(6):1217-21.
    View in: PubMed
  228. Recht A, Connolly JL, Schnitt SJ, Harris JR. Therapy of in situ cancer. Hematol Oncol Clin North Am. 1989 Dec; 3(4):691-708.
    View in: PubMed
  229. Schnitt SJ, Wang HH, Owings DV, Hann L. Sampling grossly benign breast biopsy specimens. Lancet. 1989 Oct 28; 2(8670):1038.
    View in: PubMed
  230. Epstein AH, Connolly JL, Gelman R, Schnitt SJ, Silver B, Boyages J, Rose MA, Recht A, Harris JR. The predictors of distant relapse following conservative surgery and radiotherapy for early breast cancer are similar to those following mastectomy. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):755-60.
    View in: PubMed
  231. Rose MA, Henderson IC, Gelman R, Boyages J, Gore SM, Come S, Silver B, Recht A, Connolly JL, Schnitt SJ, et al. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):711-7.
    View in: PubMed
  232. Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer. 1989 Jul 15; 64(2):448-54.
    View in: PubMed
  233. Schnitt SJ, Wang HH. Histologic sampling of grossly benign breast biopsies. How much is enough? Am J Surg Pathol. 1989 Jun; 13(6):505-12.
    View in: PubMed
  234. Boyages J, Recht A, Connolly J, Schnitt S, Rose MA, Silver B, Harris JR. Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer. Recent Results Cancer Res. 1989; 115:92-102.
    View in: PubMed
  235. Leopold KA, Recht A, Schnitt SJ, Connolly JL, Rose MA, Silver B, Harris JR. Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys. 1989 Jan; 16(1):11-6.
    View in: PubMed
  236. Connolly JL, Boyages J, Schnitt SJ, Recht A, Silen W, Sadowsky N, Harris JR. In situ carcinoma of the breast. Annu Rev Med. 1989; 40:173-80.
    View in: PubMed
  237. Recht A, Schnitt SJ, Connolly JL, Rose MA, Silver B, Come S, Henderson IC, Slavin S, Harris JR. Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. Int J Radiat Oncol Biol Phys. 1989 Jan; 16(1):3-9.
    View in: PubMed
  238. Costello TJ, Wang HH, Schnitt SJ, Ritter R, Antonioli DA. Paget's disease with extensive involvement of the female genital tract initially detected by cervical cytosmear. Arch Pathol Lab Med. 1988 Sep; 112(9):941-4.
    View in: PubMed
  239. Recht A, Silen W, Schnitt SJ, Connolly JL, Gelman RS, Rose MA, Silver B, Harris JR. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1988 Aug; 15(2):255-61.
    View in: PubMed
  240. Schnitt SJ, Silen W, Sadowsky NL, Connolly JL, Harris JR. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med. 1988 Apr 7; 318(14):898-903.
    View in: PubMed
  241. Schnitt SJ. Case selection does not permit conclusions. Am J Clin Pathol. 1988 Feb; 89(2):293.
    View in: PubMed
  242. Recht A, Connolly JL, Schnitt SJ, Silver B, Rose MA, Love S, Harris JR. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1988 Jan; 14(1):3-10.
    View in: PubMed
  243. Connolly JL, Schnitt SJ. Evaluation of breast biopsy specimens in patients considered for treatment by conservative surgery and radiation therapy for early breast cancer. Pathol Annu. 1988; 23 Pt 1:1-23.
    View in: PubMed
  244. Warren SE, Schnitt SJ, Bauman AJ, Gianelly RE, Landsberg L, Baim DS. Late onset dilated cardiomyopathy in a unique familial syndrome of hypogonadism and metabolic abnormalities. Am Heart J. 1987 Dec; 114(6):1522-4.
    View in: PubMed
  245. Osteen RT, Connolly JL, Recht A, Silver B, Schnitt SJ, Harris JR. Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer. Arch Surg. 1987 Nov; 122(11):1248-52.
    View in: PubMed
  246. Login GR, Schnitt SJ, Dvorak AM. Rapid microwave fixation of human tissues for light microscopic immunoperoxidase identification of diagnostically useful antigens. Lab Invest. 1987 Nov; 57(5):585-91.
    View in: PubMed
  247. Lederman GS, Recht A, Loeffler JS, Dubuisson D, Kleefield J, Schnitt SJ. Craniopharyngioma in an elderly patient. Cancer. 1987 Sep 1; 60(5):1077-80.
    View in: PubMed
  248. Schnitt SJ, Ciano PS, Schoen FJ. Quantitation of lymphocytes in endomyocardial biopsies: use and limitations of antibodies to leukocyte common antigen. Hum Pathol. 1987 Aug; 18(8):796-800.
    View in: PubMed
  249. Harris JR, Schnitt SJ, Connolly JL, Silen W. Conservative surgery and radiation therapy for early breast cancer. Arch Surg. 1987 Jul; 122(7):754-5.
    View in: PubMed
  250. Schnitt SJ, Antonioli DA, Jaffe B, Peppercorn MA. Granulomatous inflammation of minor salivary gland ducts: a new oral manifestation of Crohn's disease. Hum Pathol. 1987 Apr; 18(4):405-7.
    View in: PubMed
  251. Safian RD, Mandell VS, Thurer RE, Hutchins GM, Schnitt SJ, Grossman W, McKay RG. Postmortem and intraoperative balloon valvuloplasty of calcific aortic stenosis in elderly patients: mechanisms of successful dilation. J Am Coll Cardiol. 1987 Mar; 9(3):655-60.
    View in: PubMed
  252. Schnitt SJ, Connolly JL, Khettry U, Mazoujian G, Brenner M, Silver B, Recht A, Beadle G, Harris JR. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer. 1987 Feb 15; 59(4):675-81.
    View in: PubMed
  253. Winston KR, Sotrel A, Schnitt SJ. Meningeal melanocytoma. Case report and review of the clinical and histological features. J Neurosurg. 1987 Jan; 66(1):50-7.
    View in: PubMed
  254. Recht A, Connolly JL, Schnitt SJ, Cady B, Love S, Osteen RT, Patterson WB, Shirley R, Silen W, Come S, et al. Conservative surgery and radiation therapy for early breast cancer: results, controversies, and unsolved problems. Semin Oncol. 1986 Dec; 13(4):434-49.
    View in: PubMed
  255. Schnitt SJ, Vogel H. Meningiomas. Diagnostic value of immunoperoxidase staining for epithelial membrane antigen. Am J Surg Pathol. 1986 Sep; 10(9):640-9.
    View in: PubMed
  256. McKay RG, Safian RD, Lock JE, Mandell VS, Thurer RL, Schnitt SJ, Grossman W. Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation. 1986 Jul; 74(1):119-25.
    View in: PubMed
  257. Epstein HD, Schnitt SJ, Brodsky G. Lipogranulomas in lymph nodes. Arch Pathol Lab Med. 1986 Jun; 110(6):467-8.
    View in: PubMed
  258. Schnitt SJ, Wang H, Dvorak AM. Morphologic changes in primary neuroendocrine carcinoma of the skin following radiation therapy. Hum Pathol. 1986 Feb; 17(2):198-201.
    View in: PubMed
  259. Spokojny AM, Sinclair IN, Schnitt S, Paulin S, Spears JR. Uptake of hematoporphyrin derivative by valvular vegetations in experimental infective endocarditis. Circulation. 1985 Nov; 72(5):1087-91.
    View in: PubMed
  260. Recht A, Danoff BS, Solin LJ, Schnitt S, Connolly J, Botnick L, Goldberg I, Goodman RL, Harris JR. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol. 1985 Oct; 3(10):1339-43.
    View in: PubMed
  261. Recht A, Silver B, Schnitt S, Connolly J, Hellman S, Harris JR. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys. 1985 Jul; 11(7):1271-6.
    View in: PubMed
  262. Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR. Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance. Int J Radiat Oncol Biol Phys. 1985 Jul; 11(7):1277-84.
    View in: PubMed
  263. Harris JR, Connolly JL, Schnitt SJ, Cady B, Love S, Osteen RT, Patterson WB, Shirley R, Hellman S, Cohen RB, et al. The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy. Ann Surg. 1985 Feb; 201(2):164-9.
    View in: PubMed
  264. Harris JR, Recht A, Schnitt S, Connolly J, Silver B, Come S, Henderson IC. Current status of conservative surgery and radiotherapy as primary local treatment for early carcinoma of the breast. Breast Cancer Res Treat. 1985; 5(3):245-55.
    View in: PubMed
  265. Schnitt SJ, Connolly JL, Harris JR, Cohen RB. Radiation-induced changes in the breast. Hum Pathol. 1984 Jun; 15(6):545-50.
    View in: PubMed
  266. Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RB. Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer. 1984 Mar 1; 53(5):1049-57.
    View in: PubMed
  267. Schnitt SJ, Antonioli DA, Goldman H. Massive mural edema in severe pseudomembranous colitis. Arch Pathol Lab Med. 1983 Apr; 107(4):211-3.
    View in: PubMed
  268. Harris JR, Connolly JL, Schnitt SJ, Cohen RB, Hellman S. Clinical-pathologic study of early breast cancer treated by primary radiation therapy. J Clin Oncol. 1983 Mar; 1(3):184-9.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Schnitt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_